While the low expression of HLA-DR (hallmark of monocytic-MDSC) and CD86 on monocytes has previously been associated with a state of general immune paralysis in critically ill patients (12) and to a lower ability to control bacterial superinfections (66), the CD14+CD91+ subset was less investigated in COVID-19. The gene discussed is LRP1; the disease is COVID-19.